Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis
- 18 November 2013
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 14 (2), 93-97
- https://doi.org/10.1016/j.clml.2013.10.013
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Clofarabine plus low‐dose cytarabine followed by clofarabine plus low‐dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patientsCancer, 2012
- Hypomethylating Agents and Other Novel Strategies in Myelodysplastic SyndromesJournal of Clinical Oncology, 2011
- Gemtuzumab ozogamicin as first-line treatment in patients aged 70 years or older with acute myeloid leukemiaCancer, 2010
- Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemiaBlood, 2010
- Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic FactorsJournal of Clinical Oncology, 2010
- Therapy for elderly patients with acute myeloid leukemiaCancer, 2007
- Decitabine improves patient outcomes in myelodysplastic syndromesCancer, 2006
- Outcome of Induction and Postremission Therapy in Younger Adults With Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2005
- Prognosis in Therapy-Related Acute Myeloid Leukemia and Impact of KaryotypeJournal of Clinical Oncology, 2004